or
forgot password
  • cancer clinical trials in bettendorf, IA

  • Comparison of Combination Chemotherapy Regimens in Treating Older Women Who Have Undergone Surgery for Breast Cancer
    Hematology Oncology Associates of the Quad Cities
    Bettendorf, Iowa 52722
    Breast Cancer
    Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
    Hematology Oncology Associates of the Quad Cities
    Bettendorf, Iowa 52722
    Breast Cancer
    Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
    Hematology Oncology Associates of the Quad Cities
    Bettendorf, Iowa 52722
    Prostate Cancer
    Dexamethasone With or Without Thalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma
    Hematology Oncology Associates of the Quad Cities
    Bettendorf, Iowa 52722
    Multiple Myeloma and Plasma Cell Neoplasm
    Rituximab, Chemotherapy, and Filgrastim in Treating Patients With Burkitt's Lymphoma or Burkitt's Leukemia
    Hematology Oncology Associates of the Quad Cities
    Bettendorf, Iowa 52722
    Leukemia, Lymphoma
    Erlotinib and Temozolomide With Radiation Therapy in Treating Patients With Glioblastoma Multiforme or Other Brain Tumors
    Constantinou, Costas L MD (UIA Investigator)
    Bettendorf, Iowa 52722
    Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma
    Four Versus Six Cycles of Cyclophosphamide/Doxorubicin or Paclitaxel in Adjuvant Breast Cancer
    Hematology Oncology Associates of the Quad Cities
    Bettendorf, Iowa 52722
    Breast Cancer
    Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor
    Constantinou, Costas L MD (UIA Investigator)
    Bettendorf, Iowa 52722
    Adult Anaplastic Oligodendroglioma, Adult Mixed Glioma, Adult Oligodendroglioma, Recurrent Adult Brain Tumor
    Chemotherapy and Radiation Therapy After Surgery in Treating Patients With Stomach or Esophageal Cancer
    Hematology Oncology Associates of the Quad Cities
    Bettendorf, Iowa 52722
    Esophageal Cancer, Gastric Cancer
    Combination Chemotherapy in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer
    Hematology Oncology Associates of the Quad Cities
    Bettendorf, Iowa 52722
    Endometrial Cancer
    Triptorelin With Either Exemestane or Tamoxifen in Treating Premenopausal Women With Hormone-Responsive Breast Cancer
    Hematology Oncology Associates-Quad Cities
    Bettendorf, Iowa 52722
    Estrogen Receptor-positive Breast Cancer, Progesterone Receptor-positive Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer
    S0221 Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast Cancer
    Hematology Oncology Associates of the Quad Cities
    Bettendorf, Iowa 52722
    Breast Cancer
    Interferon Alfa-2b With or Without Bevacizumab in Treating Patients With Advanced Renal Cell Carcinoma (Kidney Cancer)
    Hematology Oncology Associates of the Quad Cities
    Bettendorf, Iowa 52722
    Kidney Cancer
    S0226 Anastrozole With or Without Fulvestrant as First-Line Therapy in Postmenopausal Women With Metastatic Breast Cancer
    Hematology Oncology Associates of the Quad Cities
    Bettendorf, Iowa 52722
    Breast Cancer
    Rituximab in Treating Patients With Low Tumor Burden Indolent Non-Hodgkin's Lymphoma
    Hematology Oncology Associates of the Quad Cities
    Bettendorf, Iowa 52722
    Lymphoma
    Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer
    Hematology Oncology Associates-Quad Cities

    Trial Locations
    Hematology Oncology Associates-Quad Cities
    Constantinou, Costas L MD (UIA Investigator)
    Adenocarcinoma of the Colon, Stage III Colon Cancer
    Rituximab and Combination Chemotherapy in Treating Patients With Newly Diagnosed Primary CNS Lymphoma
    Hematology Oncology Associates of the Quad Cities
    Bettendorf, Iowa 52722
    Lymphoma
    Quality of Life, Employment, and Informal Care Costs in Women Who Are Receiving Chemotherapy for Breast Cancer
    Hematology Oncology Associates of the Quad Cities
    Bettendorf, Iowa 52722
    Breast Cancer
    Octreotide in Treating Patients With Cancer-Related Malignant Ascites

    Bettendorf, Iowa 52722
    Metastatic Cancer, Unspecified Adult Solid Tumor, Protocol Specific
    Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
    Hematology Oncology Associates-Quad Cities

    Trial Locations
    Hematology Oncology Associates-Quad Cities
    Constantinou, Costas L MD (UIA Investigator)
    Adenocarcinoma of the Colon, Stage II Colon Cancer
    Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal Cancer, or Fallopian Tube Cancer
    Constantinou, Costas L MD (UIA Investigator)
    Bettendorf, Iowa 52722
    Brenner Tumor, Fallopian Tube Cancer, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Primary Peritoneal Cavity Cancer, Stage III Ovarian Epithelial Cancer, Stage IV Ovarian Epithelial Cancer
    Lapatinib for Brain Metastases In ErbB2-Positive Breast Cancer
    GSK Investigational Site
    Bettendorf, Iowa 52722
    Neoplasms, Breast
    Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
    Hematology Oncology Associates of the Quad Cities

    Trial Locations
    Hematology Oncology Associates of the Quad Cities
    Colorectal Cancer
    Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
    Hematology Oncology Associates-Quad Cities

    Trial Locations
    Hematology Oncology Associates-Quad Cities
    Constantinou, Costas L MD (UIA Investigator)
    Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIB Breast Cancer
    Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
    Hematology Oncology Associates-Quad Cities

    Trial Locations
    Hematology Oncology Associates-Quad Cities
    Constantinou, Costas L MD (UIA Investigator)
    Stage IB Non-small Cell Lung Cancer, Stage IIA Non-small Cell Lung Cancer, Stage IIB Non-small Cell Lung Cancer, Stage IIIA Non-small Cell Lung Cancer
    Eribulin Mesylate in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy
    Constantinou, Costas L MD (UIA Investigator)
    Bettendorf, Iowa 52722
    Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer, Stage IV Prostate Cancer
    Bevacizumab, Sorafenib Tosylate, and Temsirolimus in Treating Patients With Metastatic Kidney Cancer
    Hematology Oncology Associates-Quad Cities

    Trial Locations
    Hematology Oncology Associates-Quad Cities
    Constantinou, Costas L MD (UIA Investigator)
    Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage IV Renal Cell Cancer
    Fulvestrant With or Without Lapatinib in Treating Postmenopausal Women With Stage III or Stage IV Breast Cancer That is Hormone Receptor-Positive
    Hematology Oncology Associates-Quad Cities
    Bettendorf, Iowa 52722
    Recurrent Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer
    AMG 706 and Octreotide in Treating Patients With Low-Grade Neuroendocrine Tumors

    Bettendorf, Iowa 52722
    Gastrointestinal Carcinoid Tumor, Islet Cell Tumor, Neoplastic Syndrome
    Surgery With or Without Docetaxel and Leuprolide or Goserelin in Treating Patients With High-Risk Localized Prostate Cancer
    Hematology Oncology Associates of the Quad Cities
    Bettendorf, Iowa 52722
    Prostate Cancer
    Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer
    Hematology Oncology Associates-Quad Cities

    Trial Locations
    Hematology Oncology Associates-Quad Cities
    Constantinou, Costas L MD (UIA Investigator)
    Male Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer
    ALTTO (Adjuvant Lapatinib And/Or Trastuzumab Treatment Optimisation) Study; BIG 2-06/N063D
    GSK Investigational Site
    Bettendorf, Iowa 52722
    Neoplasms, Breast, Breast Cancer
    Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic Colorectal Cancer That Progressed During First-Line Therapy
    Hematology Oncology Associates-Quad Cities
    Bettendorf, Iowa 52722
    Recurrent Colon Cancer, Recurrent Rectal Cancer, Stage IVA Colon Cancer, Stage IVA Rectal Cancer, Stage IVB Colon Cancer, Stage IVB Rectal Cancer
    Early or Delayed Fludarabine and Rituximab in Treating Patients With Previously Untreated Chronic Lymphocytic Leukemia
    Hematology Oncology Associates of the Quad Cities

    Trial Locations
    Hematology Oncology Associates of the Quad Cities
    Leukemia
    First-Line Chemotherapy and Trastuzumab With or Without Bevacizumab in Treating Patients With Metastatic Breast Cancer That Overexpresses HER-2/NEU
    Constantinou, Costas L MD (UIA Investigator)
    Bettendorf, Iowa 52722
    HER2-positive Breast Cancer, Male Breast Cancer, Recurrent Breast Cancer, Stage IV Breast Cancer
    Bortezomib and Dexamethasone With or Without Lenalidomide in Treating Patients With Multiple Myeloma Previously Treated With Dexamethasone
    Constantinou, Costas L MD (UIA Investigator)
    Bettendorf, Iowa 52722
    Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma
    Epratuzumab and Rituximab in Treating Patients With Previously Untreated Follicular Non-Hodgkin Lymphoma
    Hematology Oncology Associates of the Quad Cities
    Bettendorf, Iowa 52722
    Lymphoma
    Bortezomib and Lenalidomide in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma
    Hematology Oncology Associates-Quad Cities
    Bettendorf, Iowa 52722
    Recurrent Mantle Cell Lymphoma